Association of STAT3 polymorphism with tyrosine kinase inhibitors-induced safety and efficacy in patients with metastatic renal cell carcinoma: a systematic review

2017 ◽  
pp. 69-69
Author(s):  
Chenkui Miao ◽  
Aiming Xu ◽  
Yuxiao Zheng ◽  
Chao Liang ◽  
Jundong Zhu ◽  
...  
Keyword(s):  
Systematic Review ◽  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Safety And Efficacy

scholarly journals Treatable causes of diarrhoea in patients on tyrosine kinase inhibitors for metastatic renal cell carcinoma

2019 ◽  
Vol 30 (1) ◽  
pp. 150-151
Author(s):  
S.V. Lightowlers ◽  
B. Greef ◽  
T. Eisen ◽  
A. Matakidou ◽  
K. Fife ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Kinase Inhibitors
Sign in / Sign up

Export Citation Format

Share Document